Global Health IPO Details
IPO Date	November 3, 2022 to November 7, 2022
Listing Date	November 16, 2022
Face Value	₹2 per share
Issue Price Band	₹319 to ₹336 per share
Issue Price Final	₹336 per share
Lot Size	44 Shares
Sale Type	Fresh Capital-cum-Offer for Sale
Total Issue Size	6,56,41,952 shares
(aggregating up to ₹2,205.57 Cr)
Fresh Issue	1,48,80,952 shares
(aggregating up to ₹500.00 Cr)
Offer for Sale	5,07,61,000 shares of ₹2
(aggregating up to ₹1,705.57 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre Issue	25,33,03,930 shares
Share Holding Post Issue	26,81,84,882 shares
Global Health IPO Reservation
Global Health IPO offers total 6,56,41,952 shares. Out of which 3,28,20,975 (50.00%) allocated to QIB, 1,31,28,391 (20.00%) allocated to QIB, 98,46,293 (15.00%) allocated to NII, 2,29,74,684 (35.00%) allocated to RII and 1,96,92,584 (30.00%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	3,28,20,975 (50.00%)	NA
NII (HNI) Shares Offered	98,46,293 (15.00%)	NA
Retail Shares Offered	2,29,74,684 (35.00%)	5,22,151
Total Shares Offered	6,56,41,952 (100.00%)	
Global Health IPO Anchor Investors Details
Global Health IPO raises ₹661.67 crore from anchor investors. Global Health IPO Anchor bid date is November 2, 2022. Global Health IPO Anchor Investors list

Bid Date	November 2, 2022
Shares Offered	1,96,92,584
Anchor Portion Size (In Cr.)	661.67
Anchor lock-in period end date for 50% shares (30 Days)	December 11, 2022
Anchor lock-in period end date for remaining shares (90 Days)	February 9, 2023
Global Health IPO Timeline (Tentative Schedule)
Global Health IPO opens on November 3, 2022, and closes on November 7, 2022.

IPO Open Date	Thu, Nov 3, 2022
IPO Close Date	Mon, Nov 7, 2022
Tentative Allotment	Fri, Nov 11, 2022
Initiation of Refunds	Mon, Nov 14, 2022
Credit of Shares to Demat	Tue, Nov 15, 2022
Tentative Listing Date	Wed, Nov 16, 2022
Cut-off time for UPI mandate confirmation	5 PM on Mon, Nov 7, 2022
Global Health IPO Lot Size
Investors can bid for a minimum of 44 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	44	₹14,784
Retail (Max)	13	572	₹1,92,192
S-HNI (Min)	14	616	₹2,06,976
S-HNI (Max)	67	2,948	₹9,90,528
B-HNI (Min)	68	2,992	₹10,05,312
Global Health IPO Promoter Holding
Dr. Naresh Trehan is the company promoter.
Promoter Holding Pre Issue	35%
Promoter Holding Post Issue	33%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Global Health Ltd.
Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.

In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.

As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.

Global Health Limited's hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 and was featured in the list of top 250 global hospitals in 2022 by Newsweek

Competitive Strengths:

Leading tertiary and quaternary care provider in India, well recognised for clinical expertise in particular in dealing with complicated cases.
Focus on Clinical Research and Academics.
Large-scale hospitals with world-class infrastructure, high-end medical equipment, and technology.
Track record of strong operational and financial performance.
Focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna).
Growth opportunities in existing facilities and diversification into new services, including digital health.
Experienced senior management team with strong institutional shareholder support.
Company Financials
Global Health Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Total Borrowing
31-Mar-20	2666.29	1544.27	36.33	1349.54	621.94
30-Jun-20	2855.11	491.58	41.76	1425.38	725.07
31-Mar-21	2694.1	1478.16	28.8	1382.34	644.6
31-Mar-22	3145.52	2205.82	196.2	1616.01	837.86
30-Jun-22	3221.94	626.54	58.71	1675.55	794.45
Amount in ₹ Crore
Key Performance Indicator (KPI)
The market capitalization of Global Health IPO is ₹9011.01 Cr.

Pre IPO	Post IPO
P/E (x)	38.36	
Objects of the Issue (Global Health IPO Objectives)
The Company Global Health IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

S.No.	Objects of the Issue	Expected Amount (₹ in crores)
1	Investment in two of our Subsidiaries, GHPPL and MHPL, in the form of debt or equity for repayment/prepayment of borrowings, in full or part, of such Subsidiaries	375.00
2	General corporate purposes	101.70
Global Health IPO Review
[Dilip Davda]  GHL is operating under the most popular healthcare brand “Medanta” and posted growth over the years in its scale of operations. The issue is attractively priced based on its financial data and well compares with listed peers. Investors may consider an investment with medium to long-term perspectives. Read detail review...

Global Health IPO Subscription Status (Bidding Detail)
The Global Health IPO is subscribed 9.58 times on November 7, 2022 7:00:00 PM (Day 3). The public issue subscribed 0.88 times in the retail category, 28.64 times in the QIB category, and 4.02 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	28.64	1,35,24,905	38,73,58,840
NII	4.02	99,65,248	4,00,55,620
    bNII (bids above ₹10L)	5.16	66,43,498	3,42,97,032
    sNII (bids below ₹10L)	1.73	33,21,750	57,58,588
Retail	0.88	2,32,52,244	2,05,71,188
Total	9.58	4,67,42,397	44,79,85,648
Global Health IPO Prospectus
  ›  Global Health IPO DRHP
  ›  Global Health IPO RHP
  ›  Anchor Investors in Global Health IPO
  ›  Global Health IPO Final Prospectus
Global Health IPO Listing Details
Listing Date	November 16, 2022
BSE Script Code	543654
NSE Symbol	MEDANTA
ISIN	INE474Q01031
Final Issue Price	₹336 per share
BSE Listing Group	B (Rolling)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹336.00	₹336.00
Open	₹398.15	₹401.00
Low	₹391.05	₹390.55
High	₹424.90	₹424.65
Last Trade	₹415.65	₹415.30